Eastgate Biotech Corp Other Comprehensive Income (Loss), before Tax
Eastgate Biotech Corp reported Other Comprehensive Income (Loss), before Tax of -$1.80 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2019-03-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTax · last filed 2019-03-04
- Eastgate Biotech Corp other comprehensive income (loss), before tax for the quarter ending 2017-09-30 was -$1.80M.
- Eastgate Biotech Corp other comprehensive income (loss), before tax for the quarter ending 2017-06-30 was -$707.31K.
- Eastgate Biotech Corp other comprehensive income (loss), before tax for the quarter ending 2017-03-31 was -$940.97K.
- Eastgate Biotech Corp other comprehensive income (loss), before tax for the quarter ending 2016-09-30 was -$468.69K.
- Eastgate Biotech Corp other comprehensive income (loss), before tax for fiscal 2013 was -$1.72M.
- Eastgate Biotech Corp other comprehensive income (loss), before tax for fiscal 2012 was -$622.82K.
| Period end | Other Comprehensive Income (Loss), before Tax 3 month | Other Comprehensive Income (Loss), before Tax 6 month | Other Comprehensive Income (Loss), before Tax 9 month | Other Comprehensive Income (Loss), before Tax 12 month | Other Comprehensive Income (Loss), before Tax 169 month | Other Comprehensive Income (Loss), before Tax 172 month | Other Comprehensive Income (Loss), before Tax 175 month |
|---|---|---|---|---|---|---|---|
| 2017-09-30 | -$1.80M 10-Q · filed 2019-03-04 | -$2.51M derived: sum of 2 quarters · filed 2019-03-04 | $3.41M 10-Q · filed 2019-03-04 | ||||
| 2017-06-30 | -$707.31K 10-Q · filed 2018-12-18 | -$1.65M 10-Q · filed 2018-12-18 | |||||
| 2017-03-31 | -$940.97K 10-Q · filed 2018-08-17 | ||||||
| 2016-09-30 | -$468.69K 10-Q · filed 2019-03-04 | -$938.62K derived: sum of 2 quarters · filed 2019-03-04 | -$2.42M 10-Q · filed 2019-03-04 | ||||
| 2016-06-30 | -$469.94K 10-Q · filed 2018-12-18 | -$1.95M 10-Q · filed 2018-12-18 | |||||
| 2016-03-31 | -$1.48M 10-Q · filed 2018-08-17 | ||||||
| 2014-03-31 | -$999.26K 10-Q/A · filed 2014-05-19 | -$2.08M derived: sum of 2 quarters · filed 2014-05-19 | -$2.33M derived: sum of 3 quarters · filed 2014-05-19 | -$3.46M 10-Q/A · filed 2014-05-19 | |||
| 2013-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-02 | -$1.33M derived: sum of 2 quarters · filed 2014-04-02 | -$1.72M 10-K · filed 2014-04-02 | -$2.46M 10-K · filed 2014-04-02 | |||
| 2013-09-30 | -$244.19K 10-Q · filed 2013-11-13 | -$636.21K 10-Q · filed 2013-11-13 | -$1.38M 10-Q · filed 2013-11-13 | ||||
| 2013-03-31 | -$166.49K 10-Q/A · filed 2014-05-19 | -$391.72K derived: sum of 2 quarters · filed 2014-05-19 | -$557.44K derived: sum of 3 quarters · filed 2014-05-19 | ||||
| 2012-12-31 | -$225.23K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-02 | -$390.95K derived: sum of 2 quarters · filed 2014-04-02 | -$622.82K 10-K · filed 2014-04-02 | ||||
| 2012-09-30 | -$165.72K 10-Q · filed 2013-11-13 | -$397.59K 10-Q · filed 2013-11-13 |